Verified Nov 2026
Electronics & Software
·
Boston, Massachusetts
·
Since 2013
Elucid is a Boston, Massachusetts-based medical technology company founded in 2013 that develops AI and machine learning software for the non-invasive diagnosis and treatment of cardiovascular disease. It has an estimated 100-200 employees and an estimated revenue band of $50-100M, and it is privately held. Its flagship software, ElucidVivo with PlaqueIQ technology, analyzes CT angiography images to characterize arterial plaque, and it serves the healthcare sector, including cardiology and radiology. In September 2026 the company closed a $55 million Series D financing.
Elucid at a glance
Revenue
$50-100M
Est. band
Employees
100-200
Founded
2013
Headquarters
Boston, Massachusetts
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Elucid is a Boston, Massachusetts-based medical technology company founded in 2013 that develops AI and machine learning software for the non-invasive diagnosis and treatment of cardiovascular disease. It has an estimated 100-200 employees and an estimated revenue band of $50-100M, and it is privately held. Its flagship software, ElucidVivo with PlaqueIQ technology, analyzes CT angiography images to characterize arterial plaque, and it serves the healthcare sector, including cardiology and radiology. In September 2026 the company closed a $55 million Series D financing.
At a glance
Attribute | Detail |
|---|---|
Founded | 2013 |
Headquarters | Boston, Massachusetts |
Employees | 100-200 |
Revenue | $50-100M (estimated) |
Primary capability | Electronics & Software |
What Elucid makes
Its ElucidVivo software with PlaqueIQ technology is FDA-cleared and CE-marked for analyzing CT angiography images of arterial plaque.
Products and capabilities described on the company's own site include LED (source: elucid.com).
Latest developments
2026-09-29 — Elucid Appoints Mark Miller as Chief Revenue Officer to Lead Commercial Expansion Ahead of BioIntegrated FFR-CT Launch (businesswire.com)
2026-09-03 — Imaging artificial intelligence vendor Elucid raises $55M (radiologybusiness.com)
2026-09-02 — Elucid Raises $55 Million in Oversubscribed Series D Financing | Elucid (elucid.com)
2026-07-09 — Elucid Announces First Patient Enrollment in AI-PREDICT, a Landmark International Study to Define Lesion-Level Cardiovascular Risk | Elucid (elucid.com)
2026-01-09 — Elucid Announces Broad Reimbursement for Quantitative Coronary Plaque Analysis | Elucid (elucid.com)
2025-12-03 — Elucid Gains Broad CMS Reimbursement of Coronary Plaque Analysis Using PlaqueIQ™ | Elucid (elucid.com)
Company details
Elucid is privately held and has raised over $80 million in total funding. Elucid was founded in 2013, has an estimated 100-200 employees, and is headquartered in Boston, Massachusetts.
Frequently asked questions
What does Elucid make?
Elucid is a Boston, Massachusetts-based medical technology company founded in 2013 that develops AI and machine learning software for the non-invasive diagnosis and treatment of cardiovascular disease. It has an estimated 100-200 employees and an estimated revenue band of $50-100M, and it is privately held. Its flagship software, ElucidVivo with PlaqueIQ technology, analyzes CT angiography images to characterize arterial plaque, and it serves the healthcare sector, including cardiology and radiology. In September 2026 the company closed a $55 million Series D financing.
Where is Elucid headquartered?
Elucid is headquartered in Boston, Massachusetts (399 Boylston St, Boston, Massachusetts, 02116-3305).
When was Elucid founded?
Elucid was founded in 2013.
How big is Elucid?
Elucid has an estimated 100-200 employees, with revenue in the $50-100M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.